QHSLab (USAQ) Stock Price, News & Analysis

Company Overview

QHSLab, Inc., a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. The company provides quality health score lab expert system (QHSLab), a cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and store patient information electronically in a secure database; and distributes AllergiEnd, a diagnostic related product and allergen immunotherapy treatments to primary care physicians. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. QHSLab, Inc. has a strategic alliance with Medical License Factory, LLC. QHSLab, Inc. was incorporated in 1983 and is based in West Palm Beach, Florida.

Key Stats

• Today's Range: $0.20 to $0.44
• 50-Day Range: $0.09 to $0.25
• 52-Week Range: $0.04 to $0.44
• Volume: 76,162 shs
• Average Volume: 18,896 shs
• Market Capitalization: $2.65 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

QHSLab Stock Analysis - MarketRank™

QHSLab scored higher than 8% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for QHSLab.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of QHSLab is -25.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of QHSLab is -25.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.01% of the outstanding shares of QHSLab have been sold short.

Short Interest Ratio / Days to Cover

QHSLab has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

QHSLab does not currently pay a dividend.

Dividend Growth

QHSLab does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.01% of the outstanding shares of QHSLab have been sold short.

Short Interest Ratio / Days to Cover

QHSLab has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

News and Social Media

• Score: 1.8 / 5
• News Sentiment: 0.25

News Sentiment

QHSLab has a news sentiment score of 0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for QHSLab this week, compared to 0 articles on an average week.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, QHSLab insiders have not sold or bought any company stock.

Percentage Held by Insiders

74.19% of the stock of QHSLab is held by insiders. A high percentage of insider ownership can be a sign of company health.

USAQ Stock Analysis - Frequently Asked Questions

How have USAQ shares performed this year?

QHSLab's stock was trading at $0.09 at the beginning of the year. Since then, USAQ stock has increased by 177.8% and is now trading at $0.25.
View the best growth stocks for 2024 here.

How were QHSLab's earnings last quarter?

QHSLab, Inc. (OTCMKTS:USAQ) announced its quarterly earnings results on Tuesday, November, 16th. The company reported ($0.03) EPS for the quarter, missing the consensus estimate of ($0.02) by $0.01. The firm earned $0.32 million during the quarter.

How do I buy shares of QHSLab?

Shares of USAQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of QHSLab own?

Based on aggregate information from My MarketBeat watchlists, some other companies that QHSLab investors own include American Premium Mining (HIPH), Ultrack Systems (MJLB), Meta Platforms (META), Isracann Biosciences (ISCNF), International Land Alliance (ILAL), Leef Brands (ICNAF) and Gemini Group Global (GMNI).

Company Calendar

• Last Earnings: 11/16/2021
• Today: 12/22/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:USAQ
• CUSIP: N/A
• CIK: 856984
• Web: www.usaqcorp.com
• Phone: (929) 379-6503
• Fax: N/A
• Employees: 5
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-470,000.00
• Net Margins: -3.24%
• Pretax Margin: -3.18%
• Return on Equity: N/A
• Return on Assets: -3.43%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.17
• Quick Ratio: 0.15

Sales & Book Value

• Annual Sales: $1.41 million
• Price / Sales: 1.88
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.04) per share
• Price / Book: -6.25

Miscellaneous

• Outstanding Shares: 10,593,000
• Free Float: 2,734,000
• Market Cap: $2.65 million
• Optionable: Not Optionable
• Beta: -0.82